Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7

J-B Tian1, L Cao, G-L Dong

  • 1Department of General Surgery, the Frist Medical Centre of Chinese of General Hospital, Haidian, Beijing, China. tianjingbo1226@126.com.

Abstract

Insights

Long non-coding RNA DDX11-AS1 is upregulated in colorectal cancer (CRC), promoting tumor growth and metastasis. Targeting DDX11-AS1 may offer a new therapeutic strategy for CRC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long non-coding RNAs (lncRNAs) are increasingly recognized as key regulators in cancer development.
  • LncRNA DDX11 antisense RNA 1 (DDX11-AS1) has shown aberrant expression in various tumors, prompting investigation in colorectal cancer (CRC).

Purpose of the Study:

  • To investigate the expression patterns and functional roles of lncRNA DDX11-AS1 in colorectal cancer (CRC).
  • To explore DDX11-AS1 as a potential diagnostic and therapeutic target for CRC.

Main Methods:

  • Utilized The Cancer Genome Atlas (TCGA) datasets for lncRNA identification in CRC.
  • Quantified DDX11-AS1 expression in CRC tissues and cell lines using Real Time-Polymerase Chain Reaction (RT-PCR).
  • Performed clinical significance analysis (Chi-square, Kaplan-Meier), functional assays, ChIP, and luciferase reporter assays to elucidate mechanisms.

Main Results:

  • DDX11-AS1 was significantly upregulated in CRC specimens and cell lines, partly induced by YY1.
  • Elevated DDX11-AS1 expression correlated with lymph node metastasis, advanced TNM stage, and poorer overall survival in CRC patients.
  • Knockdown of DDX11-AS1 inhibited CRC cell proliferation, migration, and invasion, while promoting apoptosis.
  • Mechanistically, DDX11-AS1 sponges miR-873, preventing CLDN7 degradation and facilitating CRC progression.

Conclusions:

  • DDX11-AS1 is a novel, independent prognostic biomarker for colorectal cancer.
  • The findings highlight DDX11-AS1 as a potential therapeutic target for improving CRC treatment outcomes.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
65.7K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.9K
Perpendicular-Axis Theorem01:16

Perpendicular-Axis Theorem

The perpendicular-axis theorem states that the moment of inertia of a planar object about an axis perpendicular to its plane is equal to the sum of the moments of inertia about two mutually perpendicular concurrent axes lying in the plane of the body.
Consider a circular disc of mass M and radius R lying along an x-y plane. The origin lies at the center of the disc, and the z-axis is perpendicular to the disc's plane. All three axes coincide at the disc's center. The moment of inertia of this...
4.5K
Parallel-axis Theorem01:06

Parallel-axis Theorem

The parallel-axis theorem provides a convenient and quick method of finding the moment of inertia of an object about an axis parallel to the axis passing through its center of mass. Consider a thin rod as an example. There is a striking similarity between the process of finding the moment of inertia of a thin rod about an axis through its middle, where the center of mass lies, and about an axis through its end using the conventional method. In the conventional method, the concept of linear mass...
8.2K